PolicyLatest
Moderna's vaccine vs. therapy naming dilemma
Moderna faces a challenge in how to label its mRNA products, debating between 'vaccine' and 'therapy.' This decision could impact public perception and regulatory pathways for future treatments.
0 upvotes
What happened
Moderna faces a challenge in how to label its mRNA products, debating between 'vaccine' and 'therapy.' This decision could impact public perception and regulatory pathways for future treatments.
Why it matters
TinyUpdate keeps the second sentence focused on why this update matters right now.